We are live on ! Find out more
GNPX icon

Genprex
GNPX

13 hedge funds and large institutions have $230K invested in Genprex in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

50% more capital invested

Capital invested by funds: $153K → $230K (+$76.6K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

13% less funds holding

Funds holding: 15 → 13 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$95.6K
2
Jane Street
Jane Street
New York
+$47.1K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.05K
5
UBS Group
UBS Group
Switzerland
+$7.05K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$10K
2
TSS
Two Sigma Securities
New York
-$4.91K
3
FIM
Freedom Investment Management
Connecticut
-$3.78K
4
HighTower Advisors
HighTower Advisors
Illinois
-$3.19K
5
Citigroup
Citigroup
New York
-$1.26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$73.2K +$95.6K +380 +2,714%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$57.6K +$8.05K +32 +12%
Jane Street
3
Jane Street
New York
$34.8K +$47.1K +187 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$27.8K +$20.4K +81 +119%
UBS Group
5
UBS Group
Switzerland
$27.4K +$7.05K +28 +24%
HIP
6
HUB Investment Partners
Texas
$2.88K +$252 +1 +7%
BlackRock
7
BlackRock
New York
$1.59K – – –
Osaic Holdings
8
Osaic Holdings
Arizona
$1.39K +$2.01K +8 New
Citigroup
9
Citigroup
New York
$1.03K -$1.26K -5 -45%
TRCT
10
Tower Research Capital (TRC)
New York
$984 – – –
SS
11
SBI Securities
Japan
$410 – – –
Morgan Stanley
12
Morgan Stanley
New York
$162 – – –
Bank of America
13
Bank of America
North Carolina
$121 – – –
HWM
14
HighMark Wealth Management
Minnesota
$85 – – –
NRG
15
Nemes Rush Group
Michigan
$42 – – –
AF
16
Allworth Financial
California
$22 – – –
Group One Trading
17
Group One Trading
Illinois
$4 – – –
GRP
18
Global Retirement Partners
California
$1 – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$1 – – –
VF
20
Virtu Financial
New York
– -$10K -39 Closed
TSS
21
Two Sigma Securities
New York
– -$4.91K -20 Closed
FIM
22
Freedom Investment Management
Connecticut
– -$3.78K -15 Closed
HighTower Advisors
23
HighTower Advisors
Illinois
– -$3.19K -13 Closed
CW
24
Curio Wealth
Maryland
– -$2 – –
Fidelity Investments
25
Fidelity Investments
Massachusetts
– -$9 – –
1
2

GNPX Hedge Fund Activity: Q3 2025 in Review

13 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2025, worth a combined $230K — up 50% from $153K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of GNPX and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $95.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $10K sold.

  • 13 institutional investors held Genprex (GNPX) as of Q3 2025, down from 15 in Q2 2025.
  • Funds reported $230K of Genprex stock for Q3 2025, up 50% quarter-over-quarter.
  • 2 funds opened new Genprex positions in Q3 2025 and 4 closed out, a net change of -2 holders.
  • The largest Genprex buyer in Q3 2025 was Vanguard Group, an estimated $95.6K added.
  • The largest Genprex seller in Q3 2025 was Virtu Financial, an estimated $10K sold.

Based on aggregated 13F filings for Q3 2025.